Log in

CNSX:PWRPharmadrug Stock Price, Forecast & News

$0.52
+0.04 (+8.33 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.50
Now: $0.52
$0.52
50-Day Range N/A
52-Week Range N/A
Volume218,670 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Captiva Verde Land Corp. operates as a health and wellness company. Its assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Just Baseball Limited and changed its name to Captiva Verde Land Corp. in March 2017. Captiva Verde Land Corp. was incorporated in 2015 and is based in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Real Estate Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive PWR News and Ratings via Email

Sign-up to receive the latest news and ratings for PWR and its competitors with MarketBeat's FREE daily newsletter.

Pharmadrug (CNSX:PWR) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Pharmadrug?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pharmadrug in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Pharmadrug.

What price target have analysts set for PWR?

1 brokers have issued 1-year target prices for Pharmadrug's stock. Their forecasts range from $0.86 to $0.86. On average, they expect Pharmadrug's share price to reach $0.86 in the next year. This suggests a possible upside of 65.4% from the stock's current price. View analysts' price targets for Pharmadrug.

Has Pharmadrug been receiving favorable news coverage?

Media headlines about PWR stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pharmadrug earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. View the latest news about Pharmadrug.

Who are some of Pharmadrug's key competitors?

Who are Pharmadrug's key executives?

Pharmadrug's management team includes the following people:
  • Mr. Jeffrey J. Ciachurski, CEO & Director (Age 60)
  • Mr. Anthony Bob Balic, Chief Financial Officer (Age 38, Pay $60k)

What is Pharmadrug's stock symbol?

Pharmadrug trades on the CNSX under the ticker symbol "PWR."

How do I buy shares of Pharmadrug?

Shares of PWR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharmadrug's stock price today?

One share of PWR stock can currently be purchased for approximately $0.52.

What is Pharmadrug's official website?

The official website for Pharmadrug is www.captiva-verde.com.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.